NRG Therapeutics

About:

NRG Therapeutics is a drug discovery company focussed on therapeutic approaches that will restore mitochondrial function.

Website: http://www.nrgtherapeutics.com/

Top Investors: Innovate UK, Michael J. Fox Foundation, Target ALS Foundation, Parkinson's UK, Brandon Capital

Description:

NRG Therapeutics is a drug discovery company focussed on therapeutic approaches that will restore mitochondrial function and slow or halt the progression of neurodegenerative diseases such as Parkinson’s disease, Alzheimer’s disease and motor neurone disease. Founded in 2018 by a team of experienced biotech and pharmaceutical industry professionals, with a background in neuroscience drug discovery, NRG Therapeutics will initially focus on the discovery and development of brain penetrant mitochondrial permeability transition pore inhibitors for the treatment of Parkinson’s disease.